Monday, February 28, 2022

KEC

KEC(KEC International Limited)

15.09.2022 - Nomura on KEC Maintain Buy CMP 450.95 Target 556

MACQUARIE ON KEC : 17.06.2021

• Maintain Outperform, Target at Rs 490/share
• Virtuous cycle of returns and growth deserves overweight allocation
* Entry into various EPC segments, efficient execution
* Capex indicates strong growth prospects for KEC over the next three years
* Strong backlog and asset-light model ensures bidding discipline
* Strong return ratios, low debt, disciplined capital allocation

ERIS

ERIS(Eris Lifesciences Ltd) 18.01.2023 -  Macquarie  on  ERIS Maintain Outperform CMP 625.75 Target 830